Betrixaban is a broad anti-virus inhibitor by activating innate immunity
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1603530 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Shiyu Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Nation…. Hauptthemen laut MEDLINE: Immunity, Innate, Antiviral Agents, Pyridines, Virus Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses, leading to broad-spectrum antiviral effects. BT induces IFN-β production and upregulates interferon-stimulated genes (ISGs), effectively suppressing the replication of multiple viruses, including vesicular stomatitis virus (VSV), herpes simplex virus type 1 (HSV-1), murine hepatitis virus strain A59 (MHV-A59), encephalomyocarditis virus (EMCV), and influenza A virus (IAV). BT’s antiviral activity relies on innate immune activation, with IRF3 playing a key role. The antiviral effect was significantly reduced upon loss of ISGs induction, including Mx1 and Mx2. In vivo , BT treatment markedly induced IFNB1 expression across multiple mouse tissues and significantly inhibited viral replication in VSV-infected wild-type mice, confirming the essential role of innate antiviral immune activation. These findings establish BT as a potent stimulator of the innate immune system, demonstrating broad-spectrum antiviral potential and highlighting its promise as a therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Systems Biomedicine, Department of Immunology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, National Health Commission (NHC) Key Laboratory of Medical Immunology, Pekin…
- Department of Orthopedics and Traumatology, Nanchong Hospital of Traditional Chinese Medicine, Nanchong, China.
- Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China.
- Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, China.
Zitieren
APA
Hu, S., Zhao, Y., Chen, X., Wang, H., Hu, W., Huang, R., Yang, J., Niu, C., Guo, X., & You, F. (2025). Betrixaban is a broad anti-virus inhibitor by activating innate immunity. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1603530
Vancouver
Hu S, Zhao Y, Chen X, Wang H, Hu W, Huang R, et al. Betrixaban is a broad anti-virus inhibitor by activating innate immunity. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1603530
BibTeX
@article{Hu2025,
author = {Hu, Shiyu and Zhao, Yang and Chen, Xingyu and Wang, Haocheng and Hu, Wenjun and Huang, Rong and Yang, Jian and Niu, Chenxi and Guo, Xuefei and You, Fuping},
title = {Betrixaban is a broad anti-virus inhibitor by activating innate immunity},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1603530}
}
EUVIMED